Background Eisenmenger syndrome (ES) is a severe and fatal complication of uncorrected congenital heart disease characterised ...

Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite therapeutic advances, the disease-associated morbidity and mortality ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

Key points A 53-year-old woman with rectosigmoid adenocarcinoma was seen in the radiation oncology clinic for her fifth and final fraction of neoadjuvant radiotherapy, where she reported chills, ...

A promising new combination therapy is offering new hope for patients with hard-to-treat cancers. This is thanks to scientists at the Fralin Biomedical Research Institute in Virginia who have ...

CT scans from a lung cancer patient treated at MSK, taken from two different views. These images show the patient’s chest before TIL therapy and again six weeks after treatment. The pretreatment ...

Small-cell lung cancer makes up approximately 15 percent of lung cancers in the United States. The strongest risk factor for this cancer is smoking tobacco. Many people with small-cell lung cancer go ...

Stage 3 non-small cell lung cancer has spread to nearby tissues and lymph nodes but not to more distant tissues. Most people with this stage have lung cancer symptoms. Treatment can depend on several ...

Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus, according to ...

A new discovery from the lab of YouYang Zhao, Ph.D., from Stanley Manne Children's Research Institute at Ann & Robert H.